(Q39995063)

16 September 2017

title

Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine (English)

1 reference

16 September 2017

0 references

0 references

0 references

1 reference

1 reference

Elizabeth K Roediger

1

1 reference

16 September 2017

Kapilan Kugathasan

2

1 reference

16 September 2017

XiZhong Zhang

3

1 reference

16 September 2017

Brian D Lichty

4

1 reference

16 September 2017

Zhou Xing

5

1 reference

16 September 2017

publication date

25 March 2008

1 reference

16 September 2017

number of pages

9

1 reference

inferred from page(s)

published in

Molecular Therapy

1 reference

16 September 2017

volume

16

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1161-1169

1 reference

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

16 September 2017

cites work

1 reference

12 December 2020

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

1 reference

12 December 2020

Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses

1 reference

12 December 2020

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

1 reference

12 December 2020

Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development

1 reference

12 December 2020

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose

1 reference

12 December 2020

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

1 reference

12 December 2020

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis

1 reference

12 December 2020

The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus.

1 reference

12 December 2020

The success and failure of BCG - implications for a novel tuberculosis vaccine

1 reference

12 December 2020

TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

1 reference

12 December 2020

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

12 December 2020

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

1 reference

12 December 2020

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge

1 reference

12 December 2020

T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls

1 reference

12 December 2020

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis

1 reference

12 December 2020

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

1 reference

12 December 2020

Viruses know it all: new insights into IFN networks

1 reference

12 December 2020

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs

1 reference

12 December 2020

Viral vectors for malaria vaccine development

1 reference

12 December 2020

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

1 reference

12 December 2020

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge

1 reference

12 December 2020

BCG vaccine. WHO position paper

1 reference

12 December 2020

Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization

1 reference

12 December 2020

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

12 December 2020

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

12 December 2020

A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector

1 reference

12 December 2020

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease

1 reference

12 December 2020

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

12 December 2020

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

12 December 2020

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization

1 reference

12 December 2020

Attenuated vesicular stomatitis viruses as vaccine vectors

1 reference

12 December 2020

Interferons and viruses: signaling for supremacy.

1 reference

12 December 2020

Immunology of tuberculosis

1 reference

12 December 2020

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

1 reference

12 December 2020

Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120.

1 reference

12 December 2020

Recombinant vesicular stomatitis viruses from DNA.

1 reference

12 December 2020

High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses

1 reference

12 December 2020

Vesicular stomatitis virus: re-inventing the bullet

1 reference

12 December 2020

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

12 December 2020

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein

1 reference

12 December 2020

Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences

1 reference

12 December 2020

Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes

1 reference

12 December 2020

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1038/MT.2008.59

1 reference

16 September 2017

0 references

1 reference